Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program

por Petrak, Russell M., Skorodin, Nathan C., Fliegelman, Robert M., Hines, David W., Chundi, Vishnu V., Harting, Brian P.
Publicado 2016

2255. The Use of Dalbavancin for Staphylococcus aureus Bacteremia in Persons Who Inject Drugs (PWID)

por Van Hise, Nicholas W, Anderson, Michael, McKinsey, David, McKinsey, Joel, Harting, Brian, Belmares, Jaime, Petrak, Russell M
Publicado 2019

Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

por Petrak, Russell M., Van Hise, Nicholas W., Skorodin, Nathan C., Fliegelman, Robert M., Chundi, Vishnu, Didwania, Vishal, Han, Alice, Harting, Brian P., Hines, David W.
Publicado 2021

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

por Petrak, Russell M., Skorodin, Nathan C., Van Hise, Nicholas W., Fliegelman, Robert M., Pinsky, Jonathan, Didwania, Vishal, Anderson, Michael, Diaz, Melina, Shah, Kairav, Chundi, Vishnu V., Hines, David W., Harting, Brian P., Sidwha, Kamo, Yu, Brian, Brune, Paul, Owaisi, Anjum, Beezhold, David, Kent, Joseph, Vais, Dana, Han, Alice, Gowda, Neethi, Sahgal, Nishi, Silverman, Jan, Stake, Jonathan, Nepomuceno, Jenie, Heddurshetti, Renuka
Publicado 2021